Skip to main content

Table 3 Baseline outcomes for all affected persons over 5 years in Australia (optimal care versus usual care)c

From: Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia

 

Option 1

Option 2

Total costs in usual care group

$2,831,006,652

$2,831,006,652

Total costs in optimal care group

$1,200,427,937

$1,126,566,791

Total incremental costs

-$1,630,578,715

-$1,704,439,861

Health system costs in usual care group

$2,516,869,902

$2,516,869,902

Health system costs in optimal care group

$1,128,856,145

$1,093,241,400

Incremental costs

-$1,388,013,757

-$1,423,628,502

Costs by Australian government in usual care group

$2,298,900,749

$2,298,900,749

Costs by Australian government in optimal care group

$1,114,692,967

$1,079,078,223

Incremental costs

-$1,184,207,781

-$1,219,822,526

Costs by State and Territory government in usual care group

$217,969,153

$217,969,153

Costs by State and Territory government in optimal care group

$14,163,177

$14,163,177

Incremental costs

-$203,805,976

-$203,805,976

Out-of-pocket costs in usual care group

$314,136,750

$314,136,750

Out-of-pocket costs in optimal care group

$71,571,792

$33,325,391

Incremental costs

-$242,564,957

-$280,811,359

Total costs of compression products in usual care groupa

$487,379,273

$487,379,273

Total costs of compression products in optimal care groupb

$539,765,074

$539,765,074

Incremental costs

$52,385,801

$52,385,801

Costs of compression products in usual care group indirectly covered by health system

$271,197,256

$271,197,256

Total costs of compression products in optimal care group covered by health system

$539,765,074

$539,765,074

Incremental costs

$268,567,818

$268,567,818

Costs of other dressings in usual care group

$37,875,018

$37,875,018

Costs of other dressings in optimal care group

$68,758,106

$68,758,106

Incremental costs

$30,883,088

$30,883,088

Total QALYs in usual care group

476,090

476,090

Total QALYs in optimal care group

504,431

504,431

Incremental QALYs

28,341

28,341

  1. aTotal costs of compression products in usual care group were covered by out-of-pocket expenditure and government’s funding to health professionals
  2. bCosts of compression products in optimal care group were covered by Australian government
  3. cCosts were measured in 2015 Australian dollars. Baseline outcomes by State and Territory are summarised in Additional file 1 Tables S6 and S7. Costs per person and QALY per person could not be calculated by dividing the total by the number of affected persons as not all affected persons received treatment and prevention for the entire 5 years in this model. By the end of 2020, patients who developed VLUs in 2016 would incur more costs associated with treatment and prevention than those who developed VLUs in 2017. Expected costs and QALYs per person over 5 years if the person received treatment and prevention for 5 years are summarised in Additional file 1: Tables S8 and S9